日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Long-Term Real-World Outcomes in Patients with Hereditary Angioedema Receiving Lanadelumab for 3 or More Years

接受 Lanadelumab 治疗 3 年或以上的遗传性血管性水肿患者的长期真实世界结果

期刊:International Archives of Allergy and Immunology
影响因子:1.8
doi:10.1159/000546987
Lumry, William R; Davis-Lorton, Mark; Soteres, Daniel; Earl, Lucy; Wynne-Cattanach, Kieran; Fox, Daniel; Sing, Krystal; Juethner, Salomé; Schultz, Bob G
发表日期：2026
文献求助 收藏

Real-world quality of life in patients with hereditary angioedema receiving lanadelumab or other long-term prophylaxis

接受拉那德鲁单抗或其他长期预防治疗的遗传性血管性水肿患者的真实世界生活质量

期刊:Allergy and Asthma Proceedings
影响因子:
doi:10.2500/aap.2026.47.250104
Davis-Lorton, Mark; Soteres, Daniel; Lumry, William R; Hall, Jennifer; Connolly, Hannah; Fox, Daniel; Sing, Krystal; Schultz, Bob G; Juethner, Salomé
发表日期：2026
文献求助 收藏

Lanadelumab for prevention of attacks of non-histaminergic normal C1 inhibitor angioedema: results from the randomized, double-blind CASPIAN Study and CASPIAN open-label extension

Lanadelumab 用于预防非组胺能正常 C1 抑制剂血管性水肿发作：来自随机、双盲 CASPIAN 研究和 CASPIAN 开放标签扩展研究的结果

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1502325
Riedl, Marc A; Staubach, Petra; Farkas, Henriette; Zanichelli, Andrea; Ren, Hong; Nurse, Christina; Andresen, Irmgard; Juethner, Salomé; Yu, Ming; Zhang, Jingmei
发表日期：2025
文献求助 收藏

Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World Study

Lanadelumab 长期预防治疗遗传性血管性水肿的持续有效性、耐受性和安全性：前瞻性、4 期、非干预性 EMPOWER 真实世界研究

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03226-3
Bernstein, Jonathan A; Betschel, Stephen D; Busse, Paula J; Banerji, Aleena; Wedner, H James; Manning, Michael; Zaragoza-Urdaz, Rafael H; Anderson, John; Gagnon, Remi; Baptist, Alan P; Soteres, Daniel; Lumry, William R; Craig, Timothy; Petroni, Daniel; Hsu, F Ida; Nova Estepan, Daniel; Juethner, Salomé; Watt, Maureen; Khutoryansky, Natalie; Zuraw, Bruce L
发表日期：2025
文献求助 收藏

Corrigendum: A novel assay of excess plasma kallikrein-kinin system activation in hereditary angioedema

更正：遗传性血管性水肿中血浆激肽释放酶-激肽系统过度激活的新检测方法

期刊:Frontiers in Allergy
影响因子:3.1
doi:10.3389/falgy.2025.1557356
Sexton, Dan; Faucette, Ryan; Rivera-Hernandez, Melody; Kenniston, Jon A; Papaioannou, Nikolaos; Cosic, Janja; Kopacz, Kris; Salmon, Gary; Beauchemin, Chantal; Juethner, Salomé; Yeung, Dave
发表日期：2025
文献求助 收藏

Comparison of real-world healthcare resource utilization and costs among patients with hereditary angioedema on lanadelumab or berotralstat long-term prophylaxis

比较接受拉那德鲁单抗或贝罗曲司他长期预防治疗的遗传性血管性水肿患者在真实世界中的医疗资源利用情况和成本

期刊:Journal of Comparative Effectiveness Research
影响因子:2.5
doi:10.57264/cer-2024-0205
Princic, Nicole; Evans, Kristin A; Shah, Chintal H; Sing, Krystal; Juethner, Salomé; Schultz, Bob G
发表日期：2025
文献求助 收藏

Hereditary angioedema plasma proteomics following specific plasma kallikrein inhibition with lanadelumab

使用lanadelumab特异性抑制血浆激肽释放酶后遗传性血管性水肿血浆蛋白质组学研究

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1471168
Sexton, Dan; Kichev, Anton; Juethner, Salomé; Yeung, Dave; MacDonald, Amanda; Anokian, Ezequiel; Li, Bin
发表日期：2024
文献求助 收藏

A novel assay of excess plasma kallikrein-kinin system activation in hereditary angioedema

遗传性血管性水肿中血浆激肽释放酶-激肽系统活化过量的新检测方法

期刊:Frontiers in Allergy
影响因子:3.3
doi:10.3389/falgy.2024.1436855
Dan Sexton, Ryan Faucette, Melody Rivera-Hernandez, Jon A Kenniston, Nikolaos Papaioannou, Janja Cosic, Kris Kopacz, Gary Salmon, Chantal Beauchemin, Salomé Juethner, Dave Yeung
信号转导
发表日期：2024
文献求助 收藏

A quantitative systems pharmacology model of plasma kallikrein-kinin system dysregulation in hereditary angioedema

遗传性血管性水肿中血浆激肽释放酶-激肽系统失调的定量系统药理学模型

期刊:Journal of Pharmacokinetics and Pharmacodynamics
影响因子:2.8
doi:10.1007/s10928-024-09919-6
Sexton, Dan; Nguyen, Hoa Q; Juethner, Salomé; Luo, Haobin; Zhang, Zhiwei; Jasper, Paul; Zhu, Andy Z X
发表日期：2024
文献求助 收藏

Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study

按遗传性血管性水肿类型划分的医生和患者报告结局：来自真实世界研究的数据

期刊:Allergy and Asthma Proceedings
影响因子:2.2
doi:10.2500/aap.2024.45.240021
Anderson, John; Soteres, Daniel; Mellor, Jennifer; Connolly, Hannah; Wynne-Cattanach, Kieran; Earl, Lucy; Schultz, Bob G; Juethner, Salome
发表日期：2024
文献求助 收藏